Company · CIK 0001832038 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Invivyd, Inc. · IVVD
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 SForm 4 → | Aug 18, 8:10 pm EDT | Timothy Edward LeeChief Commercial Officer | 40,780 | $0.7766 | $31,671 | 178,937 | −18.6% | 10b5-1 |
| Aug 17, 2026 SForm 4 → | Aug 18, 8:10 pm EDT | Julie GreenChief Human Resources Officer | 40,780 | $0.7766 | $31,671 | 168,937 | −19.4% | 10b5-1 |
| Aug 17, 2026 SForm 4 → | Aug 18, 8:10 pm EDT | William E. DukeChief Financial Officer | 40,780 | $0.7766 | $31,671 | 168,937 | −19.4% | 10b5-1 |
| Aug 17, 2026 SForm 4 → | Aug 18, 8:10 pm EDT | Jill AndersenChief Legal Officer, Secretary | 67,962 | $0.7766 | $52,781 | 283,774 | −19.3% | 10b5-1 |
| Aug 17, 2026 SForm 4 → | Aug 18, 8:10 pm EDT | Robert D. Allen IIIChief Scientific Officer | 37,722 | $0.7766 | $29,296 | 178,765 | −17.4% | 10b5-1 |
| Aug 15, 2026 MForm 4 → | Aug 18, 8:10 pm EDT | Timothy Edward LeeChief Commercial Officer | 102,000 | — | — | 219,717 | — | 10b5-1 |
| Aug 15, 2026 MForm 4 → | Aug 18, 8:10 pm EDT | Julie GreenChief Human Resources Officer | 102,000 | — | — | 209,717 | — | 10b5-1 |
| Aug 15, 2026 MForm 4 → | Aug 18, 8:10 pm EDT | William E. DukeChief Financial Officer | 102,000 | — | — | 209,717 | — | 10b5-1 |
| Aug 15, 2026 MForm 4 → | Aug 18, 8:10 pm EDT | Jill AndersenChief Legal Officer, Secretary | 170,000 | — | — | 351,736 | — | 10b5-1 |
| Aug 15, 2026 MForm 4 → | Aug 18, 8:10 pm EDT | Robert D. Allen IIIChief Scientific Officer | 102,000 | — | — | 216,487 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 AForm 4 → | Sep 2, 4:40 pm EDT | Ian SheffieldDirector | 100,000 | — | — | 100,000 | — | |
| Aug 30, 2026 AForm 4 → | Sep 1, 6:30 pm EDT | Marc EliaChief Executive Officer, Director | 10,700,000 | — | — | 10,700,000 | — | |
| Aug 15, 2026 MForm 4 → | Aug 18, 8:10 pm EDT | Timothy Edward LeeChief Commercial Officer | 102,000 | — | — | 0 | — | 10b5-1 |
| Aug 15, 2026 MForm 4 → | Aug 18, 8:10 pm EDT | Julie GreenChief Human Resources Officer | 102,000 | — | — | 0 | — | 10b5-1 |
| Aug 15, 2026 MForm 4 → | Aug 18, 8:10 pm EDT | William E. DukeChief Financial Officer | 102,000 | — | — | 0 | — | 10b5-1 |
| Aug 15, 2026 MForm 4 → | Aug 18, 8:10 pm EDT | Jill AndersenChief Legal Officer, Secretary | 170,000 | — | — | 0 | — | 10b5-1 |
| Aug 15, 2026 MForm 4 → | Aug 18, 8:10 pm EDT | Robert D. Allen IIIChief Scientific Officer | 102,000 | — | — | 0 | — | 10b5-1 |
| Jul 31, 2026 AForm 4 → | Aug 4, 4:15 pm EDT | Michael MinaCMO and Chief Epidemiologist | 1,125,000 | — | — | 1,125,000 | — |